| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 452,900 | 446,600 | 484,100 | 501,900 | | Cost of Revenue | 189,000 | 181,300 | 193,700 | 201,000 | | | Gross Profit | 263,900 | 265,300 | 290,400 | 300,900 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 123,000 | 111,100 | 141,800 | 135,200 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 38,200 | 38,100 | 41,400 | 38,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 102,700 | 116,100 | 107,200 | 127,700 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,400 | 3,500 | 1,500 | 900 | | Earnings Before Interest And Taxes | 105,100 | 118,400 | 107,200 | 126,800 | | Interest Expense | 14,300 | 17,400 | 16,900 | 17,300 | | Income Before Tax | 90,800 | 101,000 | 90,300 | 109,500 | | Income Tax Expense | 34,700 | 37,000 | 18,000 | 38,700 | | Minority Interest |
-
| (1,200) | (1,500) | (1,800) | | | | Net Income From Continuing Ops | 56,100 | 64,000 | 72,300 | 70,800 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 56,100 | 64,000 | 72,300 | 70,800 | | Preferred Stock And Other Adjustments | (1,700) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $54,400 | $64,000 | $72,300 | $70,800 |
|
0.45% Nasdaq 
0.20%
Income Statement
